Abstract
Cystinuria is a rare hereditary disorder of the renal tubular reabsorption of cystine and di-basic amino acids. The predominant clinical problem in these patients is urinary calculi related to the poor solubility of cystine in acid urine. The treatment is directed to prevent and dissolve cystine stones, and can be obtained by dilution and alkalinization of the urine. However, it is difficult to achieve a constant urinary pH higher than 7.4, and large and frequent dosages of drugs are, thus, required. We have measured the therapeutic efficacy of Uralyt-U (hexapotassium hexasodium pentacitrate hydrate complex in the form of granules, one measuring spoon containing 2.5 g) in achieving the desired urinary pH in patients with cystinuria.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Liberman, U.A., Samuel, R., Arie, R. (1989). Uralyt-U Maintains an Optimal Urinary pH in Patients with Cystinuria. In: Walker, V.R., Sutton, R.A.L., Cameron, E.C.B., Pak, C.Y.C., Robertson, W.G. (eds) Urolithiasis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0873-5_99
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0873-5_99
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0875-9
Online ISBN: 978-1-4899-0873-5
eBook Packages: Springer Book Archive